AMPK/mTOR/ULK1 Pathway Participates in Autophagy Induction by Curcumin in Colorectal Adenoma Mouse Model

IF 3.5 4区 医学 Q2 CHEMISTRY, MEDICINAL
Yuge Wang, Moxixuan Liu, Xuemei Jia, Qian Yang, Yao Du
{"title":"AMPK/mTOR/ULK1 Pathway Participates in Autophagy Induction by Curcumin in Colorectal Adenoma Mouse Model","authors":"Yuge Wang,&nbsp;Moxixuan Liu,&nbsp;Xuemei Jia,&nbsp;Qian Yang,&nbsp;Yao Du","doi":"10.1002/ddr.70115","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Colorectal adenoma (CRA) represents a pathological condition characterized by the aberrant development of intestinal epithelial cells and alterations in cellular differentiation within the colorectal mucosal epithelium, posing an increased risk for malignant transformation if not adequately addressed. Curcumin has been shown to exhibit a range of therapeutic effects across various diseases, which motivated this investigation utilizing C57BL/6 mice as a model system. Methodologies including hematoxylin-eosin staining (HE), western blot analysis, RT-PCR, immunofluorescence, and electron microscopy were employed to evaluate proteins associated with the <i>AMPK/mTOR/ULK1</i> signaling pathway. The study specifically examined variations in key autophagy-related proteins such as <i>Beclin-1, LC3, P62</i>, alongside intestinal junction proteins <i>Occludin, ZO-1, and Claudin-1</i>. This study seeks to elucidate whether curcumin can influence autophagy-related mechanisms in intestinal mucosal epithelial cells affected by colorectal adenoma to achieve potential therapeutic outcomes.</p>\n </div>","PeriodicalId":11291,"journal":{"name":"Drug Development Research","volume":"86 5","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ddr.70115","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Colorectal adenoma (CRA) represents a pathological condition characterized by the aberrant development of intestinal epithelial cells and alterations in cellular differentiation within the colorectal mucosal epithelium, posing an increased risk for malignant transformation if not adequately addressed. Curcumin has been shown to exhibit a range of therapeutic effects across various diseases, which motivated this investigation utilizing C57BL/6 mice as a model system. Methodologies including hematoxylin-eosin staining (HE), western blot analysis, RT-PCR, immunofluorescence, and electron microscopy were employed to evaluate proteins associated with the AMPK/mTOR/ULK1 signaling pathway. The study specifically examined variations in key autophagy-related proteins such as Beclin-1, LC3, P62, alongside intestinal junction proteins Occludin, ZO-1, and Claudin-1. This study seeks to elucidate whether curcumin can influence autophagy-related mechanisms in intestinal mucosal epithelial cells affected by colorectal adenoma to achieve potential therapeutic outcomes.

AMPK/mTOR/ULK1通路参与姜黄素诱导结直肠腺瘤小鼠模型自噬
结直肠腺瘤(CRA)是一种以肠上皮细胞异常发育和结直肠粘膜上皮细胞分化改变为特征的病理状态,如果不充分处理,其恶性转化的风险会增加。姜黄素已被证明对多种疾病具有一系列的治疗作用,这促使我们利用C57BL/6小鼠作为模型系统进行研究。采用苏木精-伊红染色(HE)、western blot分析、RT-PCR、免疫荧光和电镜等方法评估与AMPK/mTOR/ULK1信号通路相关的蛋白。该研究特别检测了关键自噬相关蛋白的变化,如Beclin-1、LC3、P62,以及肠连接蛋白Occludin、ZO-1和Claudin-1。本研究旨在阐明姜黄素是否可以影响受结直肠腺瘤影响的肠黏膜上皮细胞的自噬相关机制,以实现潜在的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.40
自引率
2.60%
发文量
104
审稿时长
6-12 weeks
期刊介绍: Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信